[HTML] springer.com

[HTML][HTML] New contraception update—annovera, Phexxi, Slynd, and Twirla

CC Baker, MJ Chen - Current obstetrics and gynecology reports, 2022 - Springer
Abstract Purpose of Review In this review, we discuss the efficacy, safety, and benefits of
four new contraceptive products available in the USA, specifically Annovera, Phexxi, Slynd …
被引用次数：9 相关文章

New Contraception Update-Annovera, Phexxi, Slynd, and Twirla.

CC Baker, MJ Chen - Current Obstetrics and Gynecology Reports, 2022 - europepmc.org
New Contraception Update - Annovera, Phexxi, Slynd, and Twirla. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
[HTML] nih.gov

[HTML][HTML] New Contraception Update—Annovera, Phexxi, Slynd, and Twirla

CC Baker, MJ Chen - Current obstetrics and gynecology reports, 2022 - ncbi.nlm.nih.gov
New Contraception Update — Annovera, Phexxi, Slynd, and Twirla - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

New Contraception Update-Annovera, Phexxi, Slynd, and Twirla

CC Baker, MJ Chen - Current obstetrics and gynecology …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose of review In this review, we discuss the efficacy, safety, and benefits of four new
contraceptive products available in the USA, specifically Annovera, Phexxi, Slynd, and …

New Contraception Update-Annovera, Phexxi, Slynd, and Twirla.

CC Baker, MJ Chen - Current obstetrics and gynecology reports, 2022 - escholarship.org
Purpose of reviewIn this review, we discuss the efficacy, safety, and benefits of four new
contraceptive products available in the USA, specifically Annovera, Phexxi, Slynd, and …